| Ricardo E Blanco, MD | |
|
1203 S Tyler St, Suite 200, Covington, LA 70433-2353 | |
| (985) 892-9143 | |
| (985) 892-9656 |
| Full Name | Ricardo E Blanco |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 42 Years |
| Location | 1203 S Tyler St, Covington, Louisiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1356390371 | NPI | - | NPPES |
| 1991520 | Medicaid | LA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0200X | Internal Medicine - Critical Care Medicine | 10460 (Louisiana) | Secondary |
| 207RP1001X | Internal Medicine - Pulmonary Disease | 10460 (Louisiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Tammany Parish Hospital | Covington, LA | Hospital |
| Ochsner Clinic Foundation | New orleans, LA | Hospital |
| Riverside Medical Center | Franklinton, LA | Hospital |
| Avala | Covington, LA | Hospital |
| Ochsner Medical Center - Baton Rouge | Baton rouge, LA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| St Tammany Parish Hospital Service District No 1 | 0749273761 | 138 |
| Ochsner Clinic Llc | 8224933619 | 2403 |
News Archive
Tehachapi Valley Healthcare District received $2.4 million in capital from UnitedHealth Group (NYSE: UNH) to help the organization deliver quality health care services to Tehachapi-area residents and rural communities in Kern County.
Portola Pharmaceuticals, Inc. today announced the presentation of preclinical study results for its novel Syk and JAK inhibitor program at the American Society of Hematology's 52nd Annual Meeting and Exposition. Portola's novel Syk and JAK inhibitors are in development to treat chronic inflammatory diseases, including rheumatoid arthritis, and certain cancers, including non-Hodgkin's lymphoma and chronic lymphocytic leukemia.
Altos Solutions and Oncology Metrics llc, today announced the planned merger of the two companies, creating a combined technology and knowledge data company serving community-based oncology practices. The merged company will be known as Altos Solutions and will be headquartered in Los Altos, California.
Company IberoGEN at the Miguel Hernández University of Elche (UMH) has developed a test for the early detection of coronavirus on surfaces susceptible to contamination from everyday use, such as handles, railings, switches, telephones, and keyboards, which is intended for comprehensive service companies as well as specialised entities.
› Verified 4 days ago
| Entity Name | Ochsner Clinic Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538151428 PECOS PAC ID: 8224933619 Enrollment ID: O20031126000513 |
News Archive
Tehachapi Valley Healthcare District received $2.4 million in capital from UnitedHealth Group (NYSE: UNH) to help the organization deliver quality health care services to Tehachapi-area residents and rural communities in Kern County.
Portola Pharmaceuticals, Inc. today announced the presentation of preclinical study results for its novel Syk and JAK inhibitor program at the American Society of Hematology's 52nd Annual Meeting and Exposition. Portola's novel Syk and JAK inhibitors are in development to treat chronic inflammatory diseases, including rheumatoid arthritis, and certain cancers, including non-Hodgkin's lymphoma and chronic lymphocytic leukemia.
Altos Solutions and Oncology Metrics llc, today announced the planned merger of the two companies, creating a combined technology and knowledge data company serving community-based oncology practices. The merged company will be known as Altos Solutions and will be headquartered in Los Altos, California.
Company IberoGEN at the Miguel Hernández University of Elche (UMH) has developed a test for the early detection of coronavirus on surfaces susceptible to contamination from everyday use, such as handles, railings, switches, telephones, and keyboards, which is intended for comprehensive service companies as well as specialised entities.
› Verified 4 days ago
| Entity Name | Northlake Pulmonary Associates Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144279134 PECOS PAC ID: 8123927217 Enrollment ID: O20040107000877 |
News Archive
Tehachapi Valley Healthcare District received $2.4 million in capital from UnitedHealth Group (NYSE: UNH) to help the organization deliver quality health care services to Tehachapi-area residents and rural communities in Kern County.
Portola Pharmaceuticals, Inc. today announced the presentation of preclinical study results for its novel Syk and JAK inhibitor program at the American Society of Hematology's 52nd Annual Meeting and Exposition. Portola's novel Syk and JAK inhibitors are in development to treat chronic inflammatory diseases, including rheumatoid arthritis, and certain cancers, including non-Hodgkin's lymphoma and chronic lymphocytic leukemia.
Altos Solutions and Oncology Metrics llc, today announced the planned merger of the two companies, creating a combined technology and knowledge data company serving community-based oncology practices. The merged company will be known as Altos Solutions and will be headquartered in Los Altos, California.
Company IberoGEN at the Miguel Hernández University of Elche (UMH) has developed a test for the early detection of coronavirus on surfaces susceptible to contamination from everyday use, such as handles, railings, switches, telephones, and keyboards, which is intended for comprehensive service companies as well as specialised entities.
› Verified 4 days ago
| Entity Name | St Tammany Parish Hospital Service District No 1 |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275539363 PECOS PAC ID: 0749273761 Enrollment ID: O20040406000728 |
News Archive
Tehachapi Valley Healthcare District received $2.4 million in capital from UnitedHealth Group (NYSE: UNH) to help the organization deliver quality health care services to Tehachapi-area residents and rural communities in Kern County.
Portola Pharmaceuticals, Inc. today announced the presentation of preclinical study results for its novel Syk and JAK inhibitor program at the American Society of Hematology's 52nd Annual Meeting and Exposition. Portola's novel Syk and JAK inhibitors are in development to treat chronic inflammatory diseases, including rheumatoid arthritis, and certain cancers, including non-Hodgkin's lymphoma and chronic lymphocytic leukemia.
Altos Solutions and Oncology Metrics llc, today announced the planned merger of the two companies, creating a combined technology and knowledge data company serving community-based oncology practices. The merged company will be known as Altos Solutions and will be headquartered in Los Altos, California.
Company IberoGEN at the Miguel Hernández University of Elche (UMH) has developed a test for the early detection of coronavirus on surfaces susceptible to contamination from everyday use, such as handles, railings, switches, telephones, and keyboards, which is intended for comprehensive service companies as well as specialised entities.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ricardo E Blanco, MD 1203 S Tyler St, Suite 200, Covington, LA 70433-2353 Ph: (985) 892-9143 | Ricardo E Blanco, MD 1203 S Tyler St, Suite 200, Covington, LA 70433-2353 Ph: (985) 892-9143 |
News Archive
Tehachapi Valley Healthcare District received $2.4 million in capital from UnitedHealth Group (NYSE: UNH) to help the organization deliver quality health care services to Tehachapi-area residents and rural communities in Kern County.
Portola Pharmaceuticals, Inc. today announced the presentation of preclinical study results for its novel Syk and JAK inhibitor program at the American Society of Hematology's 52nd Annual Meeting and Exposition. Portola's novel Syk and JAK inhibitors are in development to treat chronic inflammatory diseases, including rheumatoid arthritis, and certain cancers, including non-Hodgkin's lymphoma and chronic lymphocytic leukemia.
Altos Solutions and Oncology Metrics llc, today announced the planned merger of the two companies, creating a combined technology and knowledge data company serving community-based oncology practices. The merged company will be known as Altos Solutions and will be headquartered in Los Altos, California.
Company IberoGEN at the Miguel Hernández University of Elche (UMH) has developed a test for the early detection of coronavirus on surfaces susceptible to contamination from everyday use, such as handles, railings, switches, telephones, and keyboards, which is intended for comprehensive service companies as well as specialised entities.
› Verified 4 days ago
Dr. Patricia B Guidry, MD Pulmonary Disease Medicare: Medicare Enrolled Practice Location: 1000 Ochsner Blvd, Covington, LA 70433 Phone: 985-875-2828 | |
Salvatore Buttaci-guarino, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 101 Judge Tanner Blvd Ste 300, Covington, LA 70433 Phone: 985-876-2100 Fax: 985-871-1548 | |
Dr. Farhad X Aduli, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 20 Starbrush Cir, Covington, LA 70433 Phone: 985-777-7000 Fax: 985-777-9000 | |
Joe E Johnson Jr., MD Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 5001 Highway 190 East Service Rd, Suite A3, Covington, LA 70433 Phone: 985-893-9251 Fax: 985-892-7893 | |
Jessica Gonzalez, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1202 S Tyler St, Covington, LA 70433 Phone: 985-898-4194 Fax: 985-898-4164 | |
Dr. Chris Theodossiou, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1000 Ochsner Blvd, Covington, LA 70433 Phone: 985-875-2828 | |
Dr. Lauren Hamilton Mcmanus, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 350 Lakeview Ct Ste B, Covington, LA 70433 Phone: 985-730-2230 Fax: 985-730-2231 |